Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis

about

Plasma catalytic iron, AKI, and death among critically ill patients

P2860

Q34455171-61359B0B-F7F7-4BEE-AC1D-5FFF91A724C5

P2860

Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis

Item

http://www.wikidata.org/entity/Q37150884

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum catalytic Iron: A novel ...... ts on maintenance hemodialysis

@en

Serum catalytic Iron: A novel ...... s on maintenance hemodialysis.

@nl

type

Item

label

Serum catalytic Iron: A novel ...... ts on maintenance hemodialysis

@en

Serum catalytic Iron: A novel ...... s on maintenance hemodialysis.

@nl

prefLabel

Serum catalytic Iron: A novel ...... ts on maintenance hemodialysis

@en

Serum catalytic Iron: A novel ...... s on maintenance hemodialysis.

@nl

P1476

Serum catalytic Iron: A novel ...... ts on maintenance hemodialysis

@en

P2093

B N Mukhopadhyay

http://www.w3.org/2001/XMLSchema#string

K D Gohel

http://www.w3.org/2001/XMLSchema#string

M M Rajapurkar

http://www.w3.org/2001/XMLSchema#string

M R Kansara

http://www.w3.org/2001/XMLSchema#string

S D Gang

http://www.w3.org/2001/XMLSchema#string

S S Lele

http://www.w3.org/2001/XMLSchema#string

S V Shah

http://www.w3.org/2001/XMLSchema#string

T S Malavade

http://www.w3.org/2001/XMLSchema#string

U N Hegde

http://www.w3.org/2001/XMLSchema#string

P2860

Coronary artery disease in uremia: Etiology, diagnosis, and therapy.

Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.

Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro.

Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors.

The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up.

Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.

Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors.

Iron and the sex difference in heart disease risk.

High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination.

Cardiovascular disease and chronic renal disease: a new paradigm.

P304

332-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0971-4065.116293

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24049267

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

3764705

http://www.w3.org/2001/XMLSchema#string

Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis

about

P2860

P2860

Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932